Literature DB >> 25769802

Neuroprotective role of sphingosine-1-phosphate in L-BMAA treated neuroblastoma cells (SH-SY5Y).

Emma Muñoz-Sáez1, Estefanía de Munck García2, Rosa María Arahuetes Portero2, Francisca Vicente3, Francisco Javier Ortiz-López3, Juan Cantizani3, Begoña Gómez Miguel4.   

Abstract

Sphingosine-1-phosphate (S1P) is a bioactive lipid which regulates proliferation, cell migration, survival and differentiation by specific receptors activation. We studied its effects on L-BMAA treated neuroblastoma cells (SH-SY5Y), an amino acid that can trigger neurodegenerative diseases such as amyotrophic lateral sclerosis/Parkinson dementia complex (ALS/PDC). We found that S1P protects from necrosis and prevents the GSK3 increasing as long as the PI3K/AKT pathway is active. Moreover, GSK3 inhibition protects against neuronal death caused by L-BMAA.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  GSK3; Neuroprotection; SH-SY5Y; Sphingosine-1-phosphate; β-N-methylamine-l-alanine

Mesh:

Substances:

Year:  2015        PMID: 25769802     DOI: 10.1016/j.neulet.2015.03.010

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

1.  Prostaglandin EP2 Receptors Mediate Mesenchymal Stromal Cell-Neuroprotective Effects on Dopaminergic Neurons.

Authors:  Juan Andrés Parga; María García-Garrote; Salvador Martínez; Ángel Raya; José Luis Labandeira-García; Jannette Rodríguez-Pallares
Journal:  Mol Neurobiol       Date:  2017-07-17       Impact factor: 5.590

2.  Quantitative proteomics analysis of zebrafish exposed to sub-lethal dosages of β-methyl-amino-L-alanine (BMAA).

Authors:  Ann Kristin Frøyset; Essa Ahsan Khan; Kari Espolin Fladmark
Journal:  Sci Rep       Date:  2016-07-12       Impact factor: 4.379

Review 3.  Cellular and Molecular Aspects of the β-N-Methylamino-l-alanine (BMAA) Mode of Action within the Neurodegenerative Pathway: Facts and Controversy.

Authors:  Nicolas Delcourt; Thomas Claudepierre; Thomas Maignien; Nathalie Arnich; César Mattei
Journal:  Toxins (Basel)       Date:  2017-12-22       Impact factor: 4.546

Review 4.  Sphingosine 1-Phosphate Receptors and Metabolic Enzymes as Druggable Targets for Brain Diseases.

Authors:  Sara Grassi; Laura Mauri; Simona Prioni; Livia Cabitta; Sandro Sonnino; Alessandro Prinetti; Paola Giussani
Journal:  Front Pharmacol       Date:  2019-07-23       Impact factor: 5.810

Review 5.  Non-Proteinogenic Amino Acid β-N-Methylamino-L-Alanine (BMAA): Bioactivity and Ecological Significance.

Authors:  Olga A Koksharova; Nina A Safronova
Journal:  Toxins (Basel)       Date:  2022-08-07       Impact factor: 5.075

6.  β-Methylamino-L-alanine-induced protein aggregation in vitro and protection by L-serine.

Authors:  Adam W Quinn; Connor R Phillips; Jake P Violi; Joel R Steele; Michael S Johnson; Mika T Westerhausen; Kenneth J Rodgers
Journal:  Amino Acids       Date:  2021-07-20       Impact factor: 3.520

7.  Sphingosines Derived from Marine Sponge as Potential Multi-Target Drug Related to Disorders in Cancer Development.

Authors:  Renata Biegelmeyer; Rafael Schröder; Douglas F Rambo; Roger R Dresch; João L F Carraro; Beatriz Mothes; José Cláudio F Moreira; Mário L C da Frota Junior; Amélia T Henriques
Journal:  Mar Drugs       Date:  2015-08-25       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.